About this trial
The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors.
Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires.
The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.
Eligibility criteria
Qualifiers
found to meet the criteria for an eating disorder
being in need of treatment
having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves).
Disqualifiers
Eating disorders symptoms in need of emergency care
High risk for suicide
An inability to respond to the questionnaires due to e.g., lack of knowledge in Swedish.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Uppsala University Hospital
Lead sponsor
Forte
Collaborator
The Söderström König Foundation
Collaborator
Fonden för psykisk hälsa
Collaborator